PHAGE PHARMACEUTICALS, INC. Trademark

Trademark Overview

On Friday, June 18, 2010, a trademark application was filed for PHAGE PHARMACEUTICALS, INC. with the United States Patent and Trademark Office. The USPTO has given the PHAGE PHARMACEUTICALS, INC. trademark a serial number of 85066076. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 22, 2018. This trademark is owned by Phage Pharmaceuticals, Inc.. The PHAGE PHARMACEUTICALS, INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, therapeutic proteins for the prevention and treatment of human diseases
phage pharmaceuticals, inc.

General Information

Serial Number85066076
Word MarkPHAGE PHARMACEUTICALS, INC.
Filing DateFriday, June 18, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 22, 2018
Registration Number4054806
Registration DateTuesday, November 15, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Indication of Colors claimedThe color(s) dark blue, aqua and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHAGE PHARMACEUTICALS, INC."
Description of MarkThe mark consists of a design element comprised of a box with dark blue edges and an aqua center with a white design in the middle shaped like a stylized Greek letter phi, followed by the words "PHAGE PHARMACEUTICALS, INC.", with the word "PHAGE" appearing on top in dark blue and the words "PHARMACEUTICALS, INC." appearing beneath in aqua. The color white appearing outside of the box indicates background and/or transparent areas and is not part of the mark.
Goods and ServicesPharmaceutical preparations, namely, therapeutic proteins for the prevention and treatment of human diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 22, 2018
Primary Code005
First Use Anywhere DateWednesday, April 27, 2011
First Use In Commerce DateWednesday, April 27, 2011

Trademark Owner History

Party NamePhage Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePhage Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePhage Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, June 22, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, November 15, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 15, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 26, 2011NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, July 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 25, 2011EXAMINER'S AMENDMENT ENTERED
Monday, July 25, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2011EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, July 25, 2011USE AMENDMENT ACCEPTED
Friday, July 22, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 22, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 14, 2011TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, July 14, 2011AMENDMENT TO USE PROCESSING COMPLETE
Monday, June 6, 2011USE AMENDMENT FILED
Monday, July 11, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 11, 2011FINAL REFUSAL E-MAILED
Monday, July 11, 2011FINAL REFUSAL WRITTEN
Wednesday, June 8, 2011AMENDMENT FROM APPLICANT ENTERED
Wednesday, June 8, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 6, 2011PAPER RECEIVED
Monday, December 6, 2010NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, December 6, 2010PRIORITY ACTION E-MAILED
Monday, December 6, 2010PRIORITY ACTION WRITTEN
Tuesday, November 9, 2010PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, October 29, 2010WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, October 21, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 21, 2010ASSIGNED TO LIE
Thursday, October 7, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 5, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 5, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 30, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 30, 2010NON-FINAL ACTION E-MAILED
Thursday, September 30, 2010NON-FINAL ACTION WRITTEN
Sunday, September 26, 2010ASSIGNED TO EXAMINER
Wednesday, June 23, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, June 22, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 22, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals phage treatment human diseases prevention proteins preparations namely therapeutic pharmaceutical